Latest News and Press Releases

CLEVELAND, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Telos Alliance®—global leader in broadcast audio for more than three decades, announced today that it has appointed Co-CEO Scott Stiefel to the role of...

Lupin and Exeltis Announce Reimbursement Approval of NaMuscla® in Spain for the Symptomatic Treatment of Myotonia in Adults with non-dystrophic myotonic (NDM) Disorders Agreement enables sustainable...

Libmeldy® revenue totaled $5.8M in Q4 2022 and $18.8M for the full year with commercial expansion activities continuing in Europe Clinical Type B meeting with U.S. FDA to take place in early 2023...

BOSTON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced the...

Immunocore announces strategic priorities including pipeline expansion for 2023 -2024 KIMMTRAK (tebentafusp-tebn) approved in over 30 countries with continued global expansion in 2023-2024;...

Enrollment Progresses in SUNRISE-3 Global Phase 3 Registrational Trial of Bemnifosbuvir in High-Risk Non-Hospitalized Patients with COVID-19 with Interim Analysis Expected 2H23 Proof-of-Concept...

VANCOUVER, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage...

Valoe Corporation         Stock Exchange Release         9 January 2023 at 14.00 Finnish time The Board of Directors of Valoe Corporation (the "Company") has, pursuant to the terms and conditions of...

NEW YORK, TORONTO and LONDON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Amynta Group, Brit Ltd (“Brit”), a subsidiary of Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U), and Fairfax...

Announces Preliminary 2022 Financial Results GAITHERSBURG, Md., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced a sharpened strategic focus on protecting and...